Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Emmacare
AddedFeb 17, 2024
UpdatedJun 18, 2026
Emmacare

Emmacare

Emmacare: A gamified platform enabling care managers to efficiently connect and triage chronic disease patients.

HQ
New York City, NY, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize chronic disease management, Emmacare offers a gamified platform that empowers care managers to efficiently connect and triage patients. By leveraging AI technology and gamification, Emmacare engages patients through an interactive app, enhancing patient engagement and reducing care management costs. The platform supports various services including Chronic Care Management (CCM), Annual Wellness Visits (AWV), Behavioral Health Integration (BHI), and Transitional Care.

Emmacare has attracted notable investors and healthcare professionals who believe in its innovative approach to patient care. The platform's key achievements include significantly improving patient adherence and enabling care managers to handle larger patient populations effectively. Emmacare's impact is evident in its ability to streamline chronic disease management, thereby improving patient outcomes and reducing overall healthcare costs.

Emmacare - Similar Companies

EmTech Care Labs logo

EmTech Care Labs

emtechcarelabs.com

CareMax logo

CareMax

caremax.net

CareHarmony logo

CareHarmony

care-harmony.com

Empirical Health logo

Empirical Health

empirical.health

Cohort logo

Cohort

cohort.ai

H3C logo

H3C

h3ci.com

Patient Engagement Systems logo

Patient Engagement Systems

Gritwell logo

Gritwell

grit-well.com

Care2Manage logo

Care2Manage

CarePassport logo

CarePassport

carepassport.com

Caregivers Insight logo

Caregivers Insight

Care 24/7 logo

Care 24/7

care-24-7.com

Healarium logo

Healarium

healarium.com

ConnectCareHero logo

ConnectCareHero

Welldoc logo

Welldoc

welldoc.com

Emmacare - Quick Facts

Who are Emmacare's competitors?

Companies similar to Emmacare include EmTech Care Labs, CareMax, CareHarmony and Empirical Health.

When was Emmacare founded?

Emmacare was founded in 2019.

Where is Emmacare's headquarters located?

Emmacare's headquarters is located in New York City, NY, US.

When was Emmacare's last funding round?

Emmacare's most recent funding round was for $3M (USD) in March 2022.

How much has Emmacare raised to-date?

As of Mar 16, 2022, Emmacare has raised a total of $3M (USD).

How many employees does Emmacare have?

Emmacare has 30 employees as of Feb 5, 2024.

Emmacare - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Gamification
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Care Management
  • Patient Engagement
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software